Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty

Trial Profile

Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Aug 2016

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Postoperative pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2017.
    • 12 Nov 2015 Planned end date changed from 1 Dec 2015 to 1 Jun 2016, as reported by ClinicalTrials.gov.
    • 12 Nov 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Jun 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top